verified SJR 5,218 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q1 — Cardiology and Cardiovascular Medicine lock Subscription

JACC: Heart Failure

JACC: Heart Failure is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 118. It has an SJR impact factor of 5,218 and it has a best quartile of Q1. It has an SJR impact factor of 5,218.

JACC: Heart Failure focuses its scope in these topics and keywords: heart, prognosis, failure, patients, artery, chronic, dilated, disease, fellows, limited, ...

ISSN: 2213-1779

Publisher: Elsevier Inc.

Category: Cardiology and Cardiovascular Medicine

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

5,218 Q1

H-index 118

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

5,218

H-index

118

Docs (year)

316

Docs 3y

612

Total refs

6248

Cites 3y

2699

Citable 3y

246

Cites/Doc 2y

4.32

Ref/Doc

19.77

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Characterization of Pulmonary Hypertension in Heart Failure Using the Diastolic Pressure Gradient

Worsening Heart Failure

Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure

Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure

Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure

Decongestion Strategies and Renin-Angiotensin-Aldosterone System Activation in Acute Heart Failure

Death, Heart Failure, and HIV

Crystal Methamphetamine

Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure

Clinical Outcomes With Use of Erythropoiesis Stimulating Agents in Patients With the HeartMate II Left Ventricular Assist Device

Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy

SHOW MORE ARTICLES

Characterization of Pulmonary Hypertension in Heart Failure Using the Diastolic Pressure Gradient

30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries

Cerebral Hypoperfusion Is Exaggerated With an Upright Posture in Heart Failure

Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction

Cardiovascular Reactivity to Mental Stress and Mortality in Patients With Heart Failure

Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population

Beta-Blockers in Acute Heart Failure

Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure

Assessing the Accuracy of Emergency Department International Classification of Diseases Coding *

An Increased B-Type Natriuretic Peptide in the Absence of a Cardiac Abnormality Identifies Those Whose Left Ventricular Mass Will Increase Over Time

Aldosterone Antagonists and Outcomes in Real-World Older Patients With Heart Failure and Preserved Ejection Fraction

A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure

FAQs

JACC: Heart Failure has an SJR of 5,218 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for JACC: Heart Failure is 26%.

JACC: Heart Failure

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of JACC: Heart Failure?

What is the APC / publication cost?

What is the acceptance rate?